VentriPoint Diagnostics (CVE:VPT) Trading Up 15.4% – What’s Next?

VentriPoint Diagnostics Ltd. (CVE:VPT)’s share price rose 15.4% during trading on Tuesday . The stock traded as high as C$0.15 and last traded at C$0.15. Approximately 103,556 shares were traded during mid-day trading, a decline of 21% from the average daily volume of 131,321 shares. The stock had previously closed at C$0.13.

VentriPoint Diagnostics Trading Up 15.4%

The business has a 50 day simple moving average of C$0.11 and a 200-day simple moving average of C$0.11. The company has a current ratio of 0.08, a quick ratio of 6.67 and a debt-to-equity ratio of -63.20. The stock has a market capitalization of C$28.15 million, a price-to-earnings ratio of -5.00 and a beta of -0.92.

VentriPoint Diagnostics Company Profile

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.